CMP Pharma is focused on customized patient care. Our novel therapies address critical needs of younger and older patient populations with high-value, FDA-approved liquid products. CMP Pharma liquid formulations better serve patients who may be unable to swallow or have difficulty swallowing traditional formulations. Current FDA guidance recommends that drugs not be crushed/compounded if an FDA-approved alternative, such as those offered by CMP Pharma exists. We are based in eastern North Carolina and distribute our growing portfolio of semi-solid and liquid products nationwide to hospitals, care facilities, and retail channels. To learn more about us, please visit CMPpharma.com.
Tadliq® (Tadalafil) Oral Suspension, 20 mg/5 mL, the first and only FDA-approved liquid oral suspension of Tadalafil for adult patients with difficulty swallowing.